The federal government’s COVID-19 public health emergency (PHE) declaration will end on May 11, 2023. The drug poisoning PHE, first declared in 2017, is certain to be extended, as more than 100,500 fatal drug poisonings occurred in the U.S. in the 12 months ending in September 2022.
In this free, one-hour webinar, two drug policy professionals will discuss recent and anticipated federal legislative and regulatory changes, and their likely impacts on substance use disorder (SUD) prevention, treatment, recovery, and harm reduction. The speakers will address which COVID-19 PHE regulatory flexibilities will be made permanent, and which will be rolled back.
Additional topics include a new law facilitating research on the potentially therapeutic properties of cannabinoids, the elimination of the DATA 2000 waiver requirement for prescribers of buprenorphine for opioid use disorder (OUD), and new rules affecting access to methadone for OUD. The speakers will also analyze a recent report providing a glimmer of hope that substance misuse may be in decline. The session will conclude with Q&A.
This webinar is intended for people with a moderate or higher understanding of SUD prevention, treatment, recovery, and harm reduction policies and practices
Register to attend the webinar here.
Last Updated on March 27, 2023 by Aimed Alliance
